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A B S T R A C T
Purpose: People with epilepsy (PWE) are more likely to have impaired quality of life (QOL) than the
general population. We studied predictors of QOL and their interrelations in Korean PWE.
Methods: Subjects who consecutively visited outpatient clinics in four tertiary hospitals and one
secondary care hospital were enrolled. These subjects completed the Korean version of the Neurological
Disorders Depression Inventory for Epilepsy (K-NDDI-E), the Generalized Anxiety Disorder-7 (GAD-7),
the Quality of Life in Epilepsy-10 (QOLIE-10), and the Korean version of Liverpool Adverse Event Proﬁle
(K-LAEP). We evaluated the predictors of QOL by multiple regression analyses and veriﬁed the
interrelations between the variables using a structural equation model.
Results: A total of 702 PWE were eligible for the study. The strongest predictor of the overall QOLIE-10
score was the K-LAEP score (b = 0.375, p < 0.001), followed by the K-NDDI-E score (b = 0.316,
p < 0.001), seizure control (b = 0.152, p < 0.001), household income (b = 0.375, p < 0.001), and GAD-
7 score (b = 0.119, p = 0.005). These variables explained 68.7% of the variance in the overall QOLIE-31
score. Depression and seizure control had a bidirectional relationship and exerted direct effects on QOL.
These factors also exerted indirect effects on QOL by provoking adverse effects of AEDs. Anxiety did not
have a direct effect on QOL; it had only indirect effect through the adverse effects of AEDs.
Conclusion: Depression, anxiety, seizure control, and adverse effects of AEDs have complex
interrelations that determine the QOL of PWE.
 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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People with epilepsy (PWE) appear to have poorer quality of life
(QOL) than the general population not only because of the seizures
but also because of comorbid conditions such as medical,
psychiatric, and psychosocial problems.1 Moreover, when PWE
take an antiepileptic drug (AED) for a period of time, that drug can
elicit adverse effects that further impair their QOL.2 For these
reasons, the identiﬁcation of predictors of reduced QOL in PWE is
critical for improving the targeting and optimization of existing
and emerging interventions and management strategies for
epilepsy.3
Predictors of QOL in PWE have been thoroughly summarized in
a systematic review from the UK.3 This review included 93 QOL
studies that were identiﬁed by Medline, Embase, and Cochrane
Library searches up to July 2010. Increases in seizure frequency,
seizure severity, levels of depression, levels of anxiety, and theserved.
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QOL. However, age, gender, marital status, type of seizure, age at
diagnosis, and duration of epilepsy were found to be unlikely to be
associated with QOL. The predictive values of educational and
employment statuses, the number of AEDs and the adverse effects
of AEDs for QOL were not determined.
Many studies have consistently reported that the strongest
predictors of QOL in PWE are depression and anxiety among
various other factors.4–9 Depression and anxiety have been found
to be better predictors that seizure control or the adverse effects of
AEDs. However, some studies have reported that other variables
have the greatest predictive values. An Italian, multicenter study of
people with pharmacoresistant epilepsy reported that the adverse
effects of AEDs were the strongest predictor, followed by
depression symptoms, pharmacoresistance grade, age, and lack
of a driving license.10 A hospital-based, Chinese study of people
with various seizure frequencies also reported the adverse effects
of AEDs were the strongest predictor, followed by the number of
AEDs, depression symptoms, and anxiety symptoms.11 A hospital-
based, Russian study found seizure frequency to be a stronger
predictor of QOL than depression; indeed, seizure frequency was
found to be the strongest predictor in that study.12
Therefore, the factor with the strongest inﬂuence on QOL in
PWE has yet to be elucidated.
Depression and anxiety, the adverse effects of AEDs, and seizure
control are related to each other. Regarding the relationship
between seizure control and depression and anxiety, people with
drug-refractory epilepsy have been reported to exhibit higher
frequencies of depression and anxiety than those with well-
controlled epilepsy.13,14 Regarding the relationship between the
adverse effects of AEDs and depression and/or anxiety, PWE,
depression and anxiety, even those presenting with subsyndromic
types, are more likely to experience adverse effects of AEDs than
those without these disorders.15 People with pharmacoresistant
epilepsy also exhibit higher frequencies of adverse effects of AEDs
when they also have depression symptoms.10 Regarding the
relationship between seizure control and the adverse effects of
AEDs, seizure control is one of predictors of adverse effects of AEDs
in PWE.16,17 Taken together, these results suggest that complex
interrelations between these variables and their contributions to
QOL likely exist.
The interrelations between the predictors of QOL in PWE have
not been well studied. In an Asian, hospital-based study, the
interrelations between the variables in terms of their contributions
to QOL were clariﬁed in PWE.4 Depression, anxiety, seizure control,
the number of AEDs, and sleep disturbances had complex
interrelations in their contributions to QOL as documented by a
structural equation model. However, due to the relatively small
sample size, only a limited number of variables could be examined
in this study. For example, socioeconomic status, the adverse
effects of AEDs, the underlying epilepsy syndrome, and the seizure
focus were not considered as variables. Therefore, our aims were to
perform a cross-sectional study to determine the predictors of QOL
in a large sample of PWE and to clarify their interrelations.
2. Methods
2.1. Subjects
We invited subjects who consecutively visited the epilepsy
clinics of secondary and tertiary care hospitals. The subjects were
adults between the ages of 20–70 years with current diagnoses of
epilepsy who had taken one or more AEDs for at the year prior to
recruitment and were capable of providing informed consent and
agreeing to the study protocol. Subjects with insufﬁcient
information in their medical records, with mental retardation orserious medical, neurological, or psychiatric disorders that
prevented them from understanding the questionnaire and
cooperating with the study, and those who declined to complete
the questionnaires were excluded.
2.2. Study design
The multicenter trial of epilepsy and psychiatric diseases
(MEPSY) is a multicenter, cross-sectional study assessing depres-
sion, anxiety, suicidality, the burden of the adverse effects of AEDs,
and the quality of life of Korean PWE. The subjects were enrolled
consecutively beginning in November 2012 at the outpatient
epilepsy clinics of four tertiary and one secondary care hospitals
in Daegu city, which located in the southern part of Korea. This study
was performed as a part of the MEPSY study. The institutional review
board of each center approved the study, and all subjects provided
written informed consent before participating in the study. The
subjects were diagnosed according to the ILAE classiﬁcation of
seizures and epileptic syndromes.18,19All patients were interviewed
by trained epileptologists who also reviewed the subjects’ medical
charts to collect demographic, socioeconomic, and clinical informa-
tion, which was entered into a computerized database. The
socioeconomic variables included the following: having a job versus
not having a job; earning at least one million Korean won (KRW) per
month (equivalent to US$ 900 per month) versus earning less than
one million KRW per month; having a driving license versus not
having a driving license; and being married versus being divorced,
bereaved, or unmarried. The clinical variables included the
following: age at onset, disease duration, seizure type, etiology,
epilepsy syndrome, seizure control, MRI abnormality, history of
febrile convulsion, family history of epilepsy, duration of AED intake,
AED therapy regimen, and AED load. We divided the etiologies into
idiopathic/cryptogenic and symptomatic epilepsy. We divided the
epileptic syndromes into four groups: temporal lobe epilepsy (TLE),
extraTLE, generalized epilepsy, and unknown syndromes. extraTLE
included epilepsy syndromes in which the epileptic attacks
originated from the frontal, parietal, or occipital lobes. We also
divided seizure control into three groups: well-controlled epilepsy
(WCE), poorly controlled epilepsy (PCE), and uncontrolled epilepsy
(UCE). WCE was deﬁned by freedom from seizures over the
preceding year. UCE was deﬁned according to the criteria used to
determine drug-refractory epilepsy (i.e., the failure of adequate
trials of two AEDs, an average of more than one seizure per month for
18 months and no seizure-free periods longer than three months20).
PCE was deﬁned as an intermediate degree of seizure control that
did not meet the criteria for WCE or UCE. The seizure control
classiﬁcation for each PWE was determined based on information
about seizure frequency that was obtained from the medical
records. The AED load of each individual patient was estimated as
the sum of the prescribed daily dose (PDD)/deﬁned daily dose (DDD)
ratios for each AED included in the treatment regimen21where DDD
corresponds to the assumed average maintenance daily dose of a
drug that is used for its main indication.22
Eligible subjects completed several self-report questionnaires
that included the Korean version of the Neurological Disorders
Depression Inventory for Epilepsy (K-NDDI-E),23 the Generalized
Anxiety Disorder-7 (GAD-7),24 the Korean version of the Liverpool
Adverse Event Proﬁle (K-LAEP),17 and the Quality of Life in
Epilepsy-10 (QOLIE-10).25
2.3. Questionnaires
2.3.1. The Korean version of the Neurological Disorders Depression
Inventory for Epilepsy
The K-NDDI-E is a reliable and valid screening tool for the
detection of major depression in Korean PWE.23 This tool consists
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scale that ranges from 1 to 4. Total scores range from 6 to 24, and
higher scores indicate more intense depression. The Cronbach’s a
coefﬁcient is 0.898, and total scores of 12 or greater are suggestive
of major depressive disorder.
2.3.2. Generalized Anxiety Disorder-7
The GAD-7 consists of a self-report questionnaire that allows
for the rapid detection of GAD.24 Subjects are asked about how
much they have been bothered by anxiety-related problems over
the previous two weeks via seven items that they rate on a four-
point scale. Total GAD-7 score range from 0 and 21, and total scores
of 10 or greater are considered to indicate the presence of GAD. We
used a version of the GAD-7 that has been translated into a Korean
language and is freely downloadable on the Patient Health
Questionnaire website (www.phqscreeners.com).26
2.3.3. The Korean version of Liverpool Adverse Event Proﬁle
The K-LAEP is an appropriate instrument for measuring
common adverse effects of AEDs that have occurred in the
preceding four weeks.17 The K-LAEP consists of a 19-item
questionnaire. Each item is evaluated on a four-point Likert scale
on which 1 indicates that the item is never a problem; 2, rarely a
problem; 3, sometimes a problem; and 4, always or often a
problem. Total scores range from 19 to 76, and higher scores are
indicative of greater burdens of the adverse effects. The Cronbach’s
a coefﬁcient of this instrument is 0.9. In the present analysis, the
21-item version, which includes two additional items (thinking
clearly and slurred speech), was used according to the QOL study
by Baker et al.27 Therefore, the AEP scores could range from a
minimum of 21 to a maximum of 84. We considered the items that
were given three or four points to be related to the adverse effects
of AEDs.
2.3.4. 2.3.4 Quality of Life in Epilepsy-10
The Quality of Life in Epilepsy-10 (QOLIE-10) was derived from
the QOLIE-31. The Korean version of the QOLIE-10 is a valid
screening tool for measuring the QOL of Korean PWE.25 The QOLIE-
10 is comprised of seven components, ﬁve of which correspond to
single item for each of ﬁve subscales (seizure worry, overall QOL,
emotional well-being, energy/fatigue, and cognitive functioning),
one component includes two items about the effects of medica-
tions (physical effects and mental effects), and the last component
includes three items about social functioning (work, driving, and
social limitations). The ten items of the QOLIE-10 were grouped
into two factors: Epilepsy Effects/Role Functioning (i.e., driving,
social, work, physical, mental, and memory effects) and Mental
Health (i.e., overall quality of life, depression, and energy). The
Cronbach’s a was 0.843 for the Epilepsy Effects/Role Functioning
subscale and 0.606 for the Mental Health subscale. The QOLIE-10
was signiﬁcantly correlated with the source scales of the Korean
version of the QOLIE-31.
2.4. Statistical analyses
Data from continuous variables are expressed as the mean  the
SD values, and those for categorical variables are expressed as
frequencies. Not only demographic, socioeconomic, and clinical
variables but also the questionnaire scores were included as
independent variables to measure the predictors of the QOLIE-10
overall and subscale scores by multiple linear regression analyses
with stepwise selection. The probabilities of entry and exit were 0.05
and 0.1, respectively. Collinearity was addressed by performing
collinearity statistical analyses. Variables selected from the linear
regression analyses were used to construct a structural equation
model to test the interrelations between the variables and theQOLIE-10 overall score. Based on a review of previous studies,4–17 we
developed a hypothetical model that outlined the paths of depression,
anxiety, seizure control, the adverse effects of AEDs, and socioeco-
nomic burden to QOL. We hypothesized that all of these variables
directly inﬂuenced QOL directly and that depression, anxiety, and
seizure control inﬂuenced QOL indirectly through the mediation of
the adverse events of AEDs. The hypothesized path model was tested
with structural equation modeling. The model ﬁt was evaluated using
path analysis, which is a method that estimates the relative
importances of the different paths of the independent variables onto
the dependent variables. An acceptable model ﬁt was deﬁned by the
presence of a nonsigniﬁcant chi-square (x2) value, a normed ﬁt index
(NFI) 0.9, a comparative ﬁt index (CFI) 0.9, a goodness of ﬁt index
(GFI) 0.9, and a root mean square residual (RMR) 0.05. Structural
equation modeling was used to estimate the total effect of each
predictor to establish a linear model for the prediction of the overall
QOLIE-10 score that accounted for these interrelations. With the
exception of the structural equation model, all statistical analyses
were conducted with SPSS (version 19.0, IBM Inc.). LISREL 8.8 for
Windows (SSI Inc., Skokie, IL, USA) was used for the path and
structural equation modeling components of the analysis. The level of
statistical signiﬁcance was set at 0.05.
3. Results
Initially, 861 PWE were enrolled in the study. Among these
PWE, 159 were excluded due to refusal to complete the
questionnaires (n = 34), inability to complete the questionnaires
due to mental retardation (n = 49) or serious diseases (n = 50),
young age (n = 5), and old age (n = 21). Therefore, 702 PWE (mean
age: 41 years; 57.7% male) were included. The demographic and
clinical characteristics and the results of the self-report ques-
tionnaires of the eligible subjects are listed in Table 1. Approxi-
mately 50% of the patients had a job and a driving license.
Concurrent medical diseases were present in 147 patients (20.9%)
and included diabetes and other endocrinologic disorders (n = 41),
hypertension and other cardiovascular disorders (n = 37), cerebro-
vascular disease and other neurologic disorders (n = 24), hepatic
and gastrointestinal disorders (n = 20), renal disorders (n = 8), and
other diseases (n = 48). Partial onset of seizures and cryptogenic or
symptomatic etiologies accounted for greater proportions than did
generalized seizure and idiopathic etiology. Sixty-one percent of
the patients had experienced one year of seizure freedom. MRI
abnormalities were found in 281 patients (40%), and the etiologies
of these abnormalities were hippocampal sclerosis (n = 79),
vascular lesions (n = 54), traumatic injury (n = 48), congenital
anomalies (n = 45), infection (n = 37), tumor (n = 8), and others
(n = 34). The duration of AED intake was 13.9  10.7 years (range:
1–54 years). Nearly 50% of the patients had received AED mono-
therapy. The AED load was 1.5  1.2 (range 0.1–7.7). The K-NDDI-E,
GAD-7, and K-LAEP scores were 9.7  4.1 (range 6–24), 4.1  4.9
(range 0–21), and 34.0  12.4 (range 21–81), respectively. The QOLIE-
10 overall score was 76.1  18.2 (range 3–100).
The predictors of the overall QOLIE-10 score from the multiple
linear regression analyses are documented in Table 2. The
strongest predictor was the K-LAEP score (b = 0.375,
p < 0.001), followed by the K-NDDI-E score (b = 0.316,
p < 0.001), seizure control (b = 0.152, p < 0.001), the GAD-7
score (b = 0.119, p = 0.005), and household income (b = 0.101,
p < 0.001). Stepwise regression produced a ﬁve-variable model
that explained 68.7% of the variance in the overall QOLIE-10 score.
According to the standardized b, the contribution of the K-LAEP
score to the overall QOLIE-10 score was 1.19 times greater than
that of the K-NDDI-E score, 2.47 times greater than that of seizure
control, 3.15 times greater than that of the GAD-7 score, and 3.71
times greater than that of household income. The variance inﬂation
Table 1
Demographic and clinical characteristics and results from the self-report
questionnaires of the eligible subjects (n = 702).
Characteristic Mean  SD (range) or
number (%)
Age, years 41.0  12.5 (20–70)
Gender, male 405 (57.7)
Education, years 12.2  3.3 (0–20)
Job, yes 323 (46.0)
Household income, at least 1 million KRW/month 546 (77.8)
Driving license, yes 371 (52.8)
Married but no divorce or bereavement 358 (51.0)
Concurrent medical disease, yes 147 (20.9)
Age at onset, years 24.3  14.5 (0–68)
Disease duration, years 16.7  11.8 (1–57)
Seizure type, partial 558 (79.5)
Etiology, cryptogenic or symptomatic 488 (69.5)
Epilepsy syndrome
Temporal lobe epilepsy 253 (36.0)
Extratemporal lobe epilepsy 281 (40.0)
Generalized epilepsy 137 (19.5)
Unknown 31 (4.4)
Seizure control
Well-controlled epilepsy 429 (61.1)
Poorly controlled epilepsy 178 (25.4)
Uncontrolled epilepsy 95 (13.5)
MRI abnormality, abnormal 281 (40.0)
History of febrile convulsion 130 (18.5)
Family history of epilepsy 56 (8.0)
Duration of AEDs intake, years 13.9  10.7 (1–54)
Number of AEDs
Monotherapy 345 (49.2)
Duotherapy 206 (29.3)
Triple or more AEDs 151 (21.5)
AED load 1.5  1.2 (0.1–7.7)
K-NDDI-E score 9.7  4.1 (6–24)
GAD-7 score 4.1  4.9 (0–21)
K-LAEP score 34.0  12.4 (21–81)
QOLIE-10
Epilepsy effect 83.6  21.8 (0–100)
Mental health 57.1  22.0 (0–100)
Role function 84.9  19.8 (6.3–100)
Overall score 76.1  18.2 (3–100)
KRW: Korean won, MRI: magnetic resonance imaging, AEDs: antiepileptic drugs, K-
NDDI-E: Korean version of the Neurological Disorders Depression Inventory for
Epilepsy, GAD-7: Generalized Anxiety Disorder-7, K-LAEP: Korean version of the
Liverpool Adverse Event Proﬁle, QOLIE-10: Quality of Life in Epilepsy-10.
Table 3
Predictors of the QOLIE-10 subscale scores based on stepwise multiple linear
regression analyses.
Subscale and variable Standardized
coefﬁcient b
Signiﬁcance Collinearity
(VIF)
Adjusted
R2
Epilepsy Effects 0.521
K-LAEP score 0.544 <0.001 1.962
K-NDDI-E score 0.188 <0.001 1.971
AED load 0.109 <0.001 1.07
Mental Health 0.505
K-NDDI-E score 0.395 <0.001 3.143
K-LAEP score 0.171 <0.001 2.413
Seizure control 0.127 <0.001 1.103
GAD-7 score 0.155 0.004 3.563
Age 0.078 0.007 1.009
Role Functioning 0.579
K-LAEP score 0.304 <0.001 2.434
K-NDDI-E score 0.26 <0.001 3.175
Seizure control 0.176 <0.001 1.168
Household income 0.176 <0.001 1.2
GAD-7 score 0.121 0.015 3.566
Gender 0.065 0.015 1.024
Age 0.061 0.026 1.079
QOLIE-10: Quality of Life in Epilepsy-10, K-LAEP: Korean version of the Liverpool
Adverse Event Proﬁle, K-NDDI-E: Korean version of the Neurological Disorders
Depression Inventory for Epilepsy, AED: antiepileptic drug, GAD-7: Generalized
Anxiety Disorder-7.
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that they exerted independent effects without redundancy.
Although the adverse effects of AEDs signiﬁcantly determined
QOL, the duration of AED intake, AED regimen, and AED load did
not contribute to the QOL.
The predictors of the QOLIE-10 subscale scores according to the
multiple linear regression analyses are shown in Table 3. The
strongest predictors of the Epilepsy Effects and Role Functioning
subscale scores were the K-LAEP score followed by the K-NDDI-E
score. In contrast, the strongest predictors of the Mental HealthTable 2
Predictors of the overall QOLIE-10 score based on stepwise multiple linear
regression analyses.
Variable Standardized
coefﬁcient b
Signiﬁcance Collinearity
(VIF)
Adjusted R2
0.687
K-LAEP score 0.375 <0.001 2.411
K-NDDI-E score 0.316 <0.001 3.172
Seizure control 0.152 <0.001 1.164
Household income 0.101 <0.001 1.118
GAD-7 score 0.119 0.005 3.538
QOLIE-10: Quality of Life in Epilepsy-10, K-LAEP: Korean version of the Liverpool
Adverse Event Proﬁle, K-NDDI-E: Korean version of the Neurological Disorders
Depression Inventory for Epilepsy, GAD-7: Generalized Anxiety Disorder-7.subscale score were the K-NDDI-E score followed by the K-LAEP
score. AED load was the third best predictor of the Epilepsy Effects
subscale score, whereas seizure control was the third best
predictor of the Mental Health and Role Functioning subscale
score. The contribution of the K-LAEP score to the Epilepsy Effects
subscale score was 2.89 times greater than that of the K-NDDI-E
score. The contribution of the K-LAEP score to the Role Functioning
subscale score was 1.17 times greater than that of the K-NDDI-E
score. The contribution of the K-NDDI-E score to the Mental Health
subscale score was 2.31 times greater than that of the K-LAEP
score.
The complex interrelations between the variables and the
overall QOLIE-10 score are illustrated in the structure equation
model shown in Fig. 1. According to the predeﬁned criteria, the
ﬁnal model provided an excellent ﬁt to the data (x2 = 5.72,
p = 0.84; NFI = 1, CFI = 1, GFI = 0.99, and RMR = 0.011). All regres-
sion coefﬁcients were statistically signiﬁcant (p < 0.01). Bidirec-
tional relationships were noted between the K-NDDI-E score and
the GAD-7 score and between the K-NDDI-E score and seizure
control. The K-NDDI-E score, seizure control, and household
income were found to exert direct effects on the overall QOLIE-10
score. In contrast to the hypothesized path model, the GAD-7 score
did not directly affect the overall QOLIE-10 score; rather, the GAD-
7 score, K-NDDI-E score and seizure control exerted indirect effects
on the overall QOLIE-10 score through the K-LAEP score. The GAD-
7 score had the strongest effect on the K-LAEP score, followed by
the K-NDDI-E score, and seizure control.
4. Discussion
We conducted a multicenter trial to investigate QOL in Korean
PWE. Among 702 PWE, the strongest predictor of QOL was the
adverse effects of AEDs, followed by depression, seizure control,
anxiety, and household income. These variables exhibited complex
interrelations in determining QOL. Depression and seizure control
had a bidirectional relationship and exerted direct effects on QOL.
The variables also exerted indirect effects on QOL by provoking
adverse effects of AEDs. Anxiety did not have a direct effect on
QOL but had only an indirect effect mediated through adverse
effects of AEDs.
Fig. 1. Interrelations between the clinical variables and the overall Quality of Life in
Epilepsy-10 (QOLIE-10) score deﬁned by the structural equation model. Arrows
indicate direct relationships of one variable on another. The numbers denote the
standardized regression coefﬁcients (beta weights) for each path. Negatively signed
coefﬁcients indicate that, when the predictor variable score increases by one
standard deviation, the overall QOLIE-10 score decreases by the number of standard
deviations indicated by the value of the coefﬁcient. All regression coefﬁcients were
statistically signiﬁcant (p < 0.01). K-NDDI-E: Neurological Disorders Depression
Inventory for Epilepsy, GAD-7: Generalized Anxiety Disorder-7, K-LAEP: Korean
version of Liverpool Adverse Event Proﬁle.
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samples of PWE. According to a systemic review of 86 QOL
studies up to July 2010, the majority of the studies were
relatively small (median sample size: 113) cross-sectional
studies of people drawn from a single medical center.3 Because
small sample sizes result in low statistical powers, it is critical to
involve the participants in the study to the fullest extent
possible. We searched the data published in Medline since July
2010 for investigations of the predictors of QOL that involved
more than 500 PWE and found only two studies. The ﬁrst study
was a multicenter Italian study of 809 people with pharma-
coresistant epilepsy that reported that the adverse effects of
AEDs were the strongest predictor, followed by depression
symptoms, pharmacoresistance grade, age, and lack of a driving
license.10 Although this study invited only people with drug-
refractory epilepsy to participant, its results are similar to our
own. The Italian study reported that the contribution of the
adverse effects of AEDs to QOL was 1.13 times higher than that of
depression symptoms, and this ratio is nearly identical to the
ratio we found. However, unlike our study, seizure frequency
was not a predictor of QOL in the Italian study. Because
meaningful improvements in QOL have been reported only
when complete seizure freedom is achieved,28 it is difﬁcult to
anticipate signiﬁcant improvement in the QOL of people with
drug-refractory epilepsy regardless of whether they exhibit low
or high seizure frequency. In our study, 61.1% of eligible subjects
had WCE; thus, seizure frequency was a predictor of QOL. The
Italian study did not include anxiety or household income among
the variables that could potentially determine QOL, but we found
that these variables were also predictors of QOL. The second
study was a hospital-based, US study of 1931 PWE that reported
that the two most clinically signiﬁcant predictors of QOL were
seizure severity and depression based on multivariate model-
ing.7 In contrast to our study, seizure control was not a
signiﬁcant predictor. In this study, the Liverpool Seizure Severity
Scale (LSSS) was used to measure seizure severity; this scale
includes patients’ perceptions of seizure control, the character-
istics of the seizures, the after-effects of the seizures such as loss
of consciousness, injury, incontinence, and postictal confusion.29Accordingly, the effect of seizure severity on QOL was likely to be
stronger than that of seizure control in that study. We could not
consider seizure severity as a variable that potentially deter-
mined QOL because no instrument that measured seizure
severity has yet been developed or validated in Korea. In
contrast to our study, the US study did not consider the adverse
effects of AEDs or anxiety as variables that could potentially
determine QOL. Because these two variables were found to be
predictors in our study, a complete study utilizing both of these
variables and the LSSS score should be conducted.
One strength of our study is the elucidation of interrelations
among the predictors of QOL in a large sample of PWE.
Bidirectional relationships were noted between depression and
anxiety and between depression and seizure control. The
coexistence of depression and anxiety has been well documented
in PWE. Among 85 patients with depression or anxiety disorders
as diagnosed according to the criteria of the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV-
TR), 21 (24.7%) had concurrent depression and anxiety dis-
orders.15 In a Korean, hospital-based study, 71 of 173 PWE (41%)
who exhibited depression or anxiety had combined symptoms.14
Based on these results, we suggest that depression and anxiety
have a bidirectional relationship. A close relationship between
depression and seizure control has also been reported. In a
retrospective study from the UK, the predictors of pharmacore-
sistance were investigated in 780 patients with newly diagnosed
epilepsy who were followed over a 20-year period.30 Depression
preceding the onset of the seizure disorder was associated with a
greater than twofold increase in the risk of developing
pharmacoresistant epilepsy. However, the opposite relationship
has also been well documented. In a study conducted in two
primary care practices in the UK, the frequencies of depression
were 33% in patients with frequent seizures and 6% in patients
with seizure freedom.31 In a Korean survey, patients with
uncontrolled epilepsy also exhibited higher rates of depression
compared to those with poorly controlled or well-controlled
epilepsy.14 Together, these results may reﬂect the existence of a
bidirectional relationship between depression and seizure
control. We found that depression, seizure control, and house-
hold income exerted direct effects on QOL, which are intuitive
results because depression and seizure control have been found
to be major predictors of QOL in many studies.3–12,27,28 Economic
variables, including family income, have been evaluated in only a
few studies; therefore, there is insufﬁcient information to
comment on their associations with QOL.3 Only two recent
studies included economic status as a variable. In a Chinese,
hospital-based study, economic status was found to be the third
best predictor of QOL followed by seizure severity and age.32
However, this study did not consider depression or anxiety as
variables; thus, it was unable to elucidate the effect of economic
status on QOL in relation to these symptoms. In another hospital-
based study from Korea, economic status was found to be the
fourth best predictor of QOL and was followed by depression, the
adverse effects of AEDs, and education level.6 However, this study
examined patients with well-controlled epilepsy; thus, this study
could not examine the effect of economic status on QOL in
relation to seizure control. Our study demonstrated that
economic status was a predictor of QOL independent of
depression and seizure control.
One of the interesting ﬁndings from the structure equation
model clariﬁes the causal relationships between depression,
anxiety, seizure control, and the adverse effects of AEDs.
Regarding the relationships between the adverse effects of AEDs
and depression or anxiety, two hospital-based studies of PWE
with depression and/or anxiety found that these patients are
more likely to exhibit adverse effects of AEDs than are those
S.-J. Lee et al. / Seizure 23 (2014) 762–768 767without these disorders.10,15 Regarding the relationship between
seizure control and the adverse effects of AEDs, seizure control
has been found to be one of the predictors that determine the
adverse effects of AEDs in PWE.16,17 However, the causal
relationship between the variables was not deduced in those
studies. We concluded that depression, anxiety, and seizure
control exerted indirect effects on QOL that were mediated by the
adverse effects of AEDs. In other words, although the adverse
effects of AEDs were the strongest predictor of QOL, their effect on
QOL was affected by these other variables. Anxiety did not
directly inﬂuence QOL, but it had an indirect effect on QOL that
was mediated by the increased effect of anxiety on the adverse
effects of AEDs compared to the effects of depression and seizure
control on the adverse effects of AEDs.
This study has some limitations. First, eligible subjects were
enrolled at secondary and tertiary care hospitals; thus, the
predictors of QOL in this population might be different from
those in the community population of PWE. Second, we did not use
a structured interview, such as the Structured Clinical Interview for
DSM-IV Axis I disorders (SCID),33 which is considered the gold
standard for research on psychiatric problems. However, this
interview requires a long time to complete and cannot be used in
busy clinical settings. Therefore, we utilized the K-NDDI-E and the
GAD-7 rather than the SCID. Third, our study was cross-sectional
and therefore only allowed for the assessment of the association of
the analyzed variables with QOL at a single point in time across the
cohort of patients. A prospective study might allow for the
examination of the variables that associated with changes in QOL
over time and/or as the effects of speciﬁc interventions.
Epilepsy management has traditionally focused on seizure
control with AEDs and adjunctive treatments that seeks to
decrease seizure frequency and severity. However, our ﬁndings
suggest that effective management might also depend on the early
detection of comorbid psychiatric symptoms and the recognition
of economic burdens. Unfortunately, most clinicians have limited
time to communicate with patients and might fail to ask about
these issues. In such situations, simple screening tools for the
detection of depression and anxiety can be effective. The use of the
K-NDDI-E to measure depression has been recommended,23 and
the GAD-7 has been recommended for the measurement of anxiety
in busy clinical settings.34 The rapid detection and appropriate
management of psychiatric symptoms could directly improve QOL
or reduce the perception of side effects associated with AEDs and
subsequently ameliorate QOL. Epilepsy generates a substantial
economic burden on individuals and society,35 and increased
health and societal expenditures could reduce this burden. A future
prospective study is required to determine whether minimizing
psychiatric symptoms and decreasing economic burden and
seizure freedom can improve the QOL of PWE.
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